Ketogenic Diet and Epilepsy: What We Know So Far

Area of Science:

• Neurology
• Nutritional Science
• Metabolic Disorders

Background:

• The Ketogenic Diet (KD) has been utilized for intractable epilepsy treatment since the 1920s.
• It mimics fasting benefits, a practice noted in historical medical texts.
• The KD is characterized by high fat (90%) and low protein/carbohydrate content.

Purpose of the Study:

• To review the Ketogenic Diet's efficacy and mechanisms for epilepsy treatment.
• To explore the applicability and side effects of KD and its variants.
• To assess evidence for palatable alternatives like the Modified Atkins Diet (MAD) and Low Glycemic Index Diet (LGID).

Main Methods:

• Literature review of studies on Ketogenic Diet and epilepsy.
• Analysis of proposed mechanisms of action for KD.
• Evaluation of clinical evidence for KD, MAD, and LGID in pediatric and adult populations.

Main Results:

• KD is a viable alternative for pharmacoresistant epilepsy patients unresponsive to surgery.
• Individualized diet plans are crucial, with less-restrictive options often preferred.
• MAD and LGID show promise as more palatable KD variants.

Conclusions:

• The Ketogenic Diet and its variants are effective therapeutic options for epilepsy.
• Personalized dietary approaches, considering palatability, enhance treatment adherence.
• Further research supports KD and its modifications for managing epilepsy across age groups.